Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure
Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Koen Kas, Filip D’hondt, Katleen Verleysen, Piet Moerman, Corinne Collet(Northwestern University), Wouter Laroy, Jozef Bartúnek(University of Oxford), Huw Davies, James L. Januzzi(Harvard University), J. Wuyts, Griet Vanpoucke(The Queen's Medical Research Institute), Natalie Van Landuyt, Jane‐Lise Samuel(Université Paris Cité), Marc Vanderheyden(Onze Lieve Vrouwziekenhuis Hospital), Robin Tuytten, Elisabeth Verschuere, Alain Cohen‐Solal(Inserm), Damien Logeart(Inserm), Caroline Vanhaute, Jean‐Marie Launay(Université Claude Bernard Lyon 1), Lies Vanneste, Koen De Cremer, Miguel Tavares(Hospital de Santo António), Grégoire Thomas, Christian Mueller(Immutep (Germany)), Brice Lortat‐Jacob(Université Paris Cité)
Cited by 82
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k